contributed content
Contributed: How femtech is breaking the taboo around women’s health and closing the gender health …
Lina Chan, CEO and founder of Parla reviews femtech's roles in tackling taboo subjects in women's health and outlines the importance of involving women affected in the design process.
Investment firm Kuwait Life Sciences Company's Dr. Mussaad M. Al-Razouki gives a breakdown of recently filed or finalized digital health SPACs, as well as a list of unicorns ripe for a potential merger.
J.P. Morgan's Stuart Hanson outlines three strategies for organizations looking to keep pace with digital transformation spurred by COVID-19.
Digital health and data experts illustrate the risk of sharing anonymized fitness data and call for systematic reform.
Dr. Liz Kwo reviews the support that fertility and maternal-health apps can provide and outlines key considerations for integrating these tools into care.
Flare Capital's Alexandra Mullin and Ian Chiang outline COVID-19's impact on the worsening opioid crisis and how the digital opioid use disorder space is likely to develop over the coming years.
Asset Management Ventures' Skip Fleshman outlines COVID-19's impact on clinical trials and the resulting leap toward tech-enabled decentralized trials.
Contributed: Discipline during a gold rush? Yes, now more than ever when healthcare data is involved
Echo Health Ventures Partner Jessica Zeaske offers advice to the digital health startups collecting, transmitting or transforming healthcare data.
Former Propeller Health COO and CCO Chris Hogg discusses the recent embrace of virtual care technologies and how overcoming geographic limitations could lead to a shakeup among incumbent organizations resistant to change.
As the agency's workload swells with the weight of a public health emergency, digital health companies on a timeline should consider whether their products truly warrant a regulatory submission, writes Epstein Becker & Green's Bradley Merrill Thompson.